University of Michigan
Ann Arbor, MI, United States
Dr. Kahlenberg is a Professor of Internal Medicine and Dermatology at the University of Michigan. She completed her BS in Biology (Summa Cum Laude) at Denison University, her MD, PhD, and Internal Medicine training at Case Western Reserve University and her fellowship in Rheumatology at the University of Michigan. Her clinical work is centered on the care of complicated lupus patients, including those with refractory skin disease. Her independent research laboratory (est. 2013) is funded by multiple NIH and foundation awards and combines translational approaches using patient samples and murine models to uncover the mechanisms that drive lupus and other autoimmune diseases. In particular, she is focused on unraveling the pathogenic mechanisms in cutaneous lupus, the factors that drive photosensitivity, and how skin inflammation can influence systemic lupus activity. She is the inaugural Giles Bole and Dorothy Mulkey Research Chair in Rheumatology at U-M and has received national recognition from the Lupus Foundation of America (2018 Mary Betty Stevens Award), the President of the United States (2018 PECASE recipient), and the American College of Rheumatology (2022 Henry Kunkel Young Investigator awardee). In 2023, she was admitted into the Henry Kunkel Society and the American Society of Clinical Investigation. In her spare time, she enjoys organic gardening, working on the family farm “EMMA Acres”, and spending time with her husband and children.
Ultraviolet-Mediated Damage to Mitochondria in Systemic Lupus Erythematosus
Sunday, October 26, 2025
9:00 AM – 9:30 AM Central Time
Disclosure(s): AnaptysBio: Advisor or Review Panel Member (Terminated, May 1, 2024); Biogen: Advisor or Review Panel Member (Ongoing), Consultant (Ongoing); Boehringer-Ingelheim: Advisor or Review Panel Member (Ongoing); Bristol-Myers Squibb(BMS): Advisor or Review Panel Member (Terminated, November 30, 2024), Grant/Research Support (Terminated, November 30, 2024); EMD Serano: Advisor or Review Panel Member (Ongoing); Exo Therapeutics: Consultant (Terminated, July 1, 2024); Gilead: Consultant (Ongoing); GlaxoSmithKlein(GSK): Advisor or Review Panel Member (Ongoing); Related Science LLC: Consultant (Ongoing); Rome Therapeutics: Advisor or Review Panel Member (Ongoing), Grant/Research Support (Ongoing); Seismic Therapeutics: Advisor or Review Panel Member (Ongoing); Synthekine: Advisor or Review Panel Member (Terminated); Ventus Therapeutics: Consultant (Ongoing), Grant/Research Support (Ongoing); Vividion: Advisor or Review Panel Member (Ongoing)
Immunophenotyping in Juvenile Dermatomyositis
Sunday, October 26, 2025
1:00 PM – 1:30 PM Central Time
Disclosure information not submitted.
